Cefixime 400 mg SR + Moxifloxacin 400 mg SR Film-Coated Tablet

Cefixime 400 mg SR + Moxifloxacin 400 mg SR Film-Coated Tablet is a sustained-release film-coated tablet formulated with Cefixime 400 mg SR + Moxifloxacin 400 mg SR. The active ingredient profile is Cefixime; Moxifloxacin, placing the product in the sustained-release antibiotic combination category. This product combines cefixime with the fluoroquinolone moxifloxacin; both are antibacterial agents with different mechanisms and the SR designation should be interpreted according to the approved label. The sustained-release designation indicates a modified-release presentation and must be described and used exactly according to the approved product literature. For website cataloguing, the composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. This product is intended for professional pharmaceutical presentation and should not be described using unapproved efficacy, cure or superiority claims. Clinical selection should depend on the patient, diagnosis, susceptibility or symptom profile, and the prescriber’s judgement. Prescription status, contraindications, precautions, interactions, adverse-effect information and dosing must be checked against the current approved label before publication. Manufacturer, licence, storage, shelf-life, pack configuration and market-specific regulatory details should be added only from verified product documentation.